OneMedNet (ONMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.75, +0.85% vs the prior close of $4.71.
- Volume 28.30K shares, 0.5x its 50-day average (light).
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
ONMD rises 0.8% to $4.75, 3 up days in a row. Closed at $4.75, +0.85% vs the prior close of $4.71. Day range $4.40–$4.79, opened at $4.63.
ONMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ONMD rises 0.8% to $4.75, 3 up days in a row
- Closed at $4.75, +0.85% vs the prior close of $4.71. Day range $4.40–$4.79, opened at $4.63.
- Volume was 28.30K shares, 0.5x its 50-day average of 53.90K — lighter than usual.
- Price is -21.2% vs its 50-day average ($6.03) and -37.4% vs its 200-day average ($7.59).
- 52-week range $3.61–$31.00; today's close sits at 4% of that range, 84.7% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — ONMD jumps 17.2% to $4.71 on 2.0x normal volume
- Closed at $4.71, +17.16% vs the prior close of $4.02. Day range $4.12–$4.71, opened at $4.41.
- Volume was 104.60K shares, 2.0x its 50-day average of 52.95K — unusually heavy trading.
- Price is -22.3% vs its 50-day average ($6.06) and -38.2% vs its 200-day average ($7.62).
- 52-week range $3.61–$32.00; today's close sits at 4% of that range, 85.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — ONMD rises 2.3% to $4.02
- Closed at $4.02, +2.29% vs the prior close of $3.93. Day range $3.61–$4.07, opened at $3.88.
- Volume was 37.10K shares, 0.7x its 50-day average of 52.94K.
- Price is -34.2% vs its 50-day average ($6.11) and -47.5% vs its 200-day average ($7.66).
- 52-week range $3.61–$34.40; today's close sits at 1% of that range, 88.3% below the 52-week high.
Oct 12, 2026 — ONMD slides 8.6% to $3.93, a 52-week low, 8 down days in a row
- Closed at $3.93, -8.60% vs the prior close of $4.30. Day range $3.90–$4.22, opened at $4.18.
- Volume was 42.80K shares, 0.8x its 50-day average of 53.99K.
- Price is -36.4% vs its 50-day average ($6.18) and -49.0% vs its 200-day average ($7.71).
- 52-week range $3.90–$42.20; today's close sits at 0% of that range, 90.7% below the 52-week high.
- That makes 8 straight losses.
Oct 9, 2026 — ONMD slides 10.8% to $4.30, a 52-week low, 7 down days in a row
- Closed at $4.30, -10.79% vs the prior close of $4.82. Day range $4.30–$4.84, opened at $4.79.
- Volume was 24.70K shares, 0.4x its 50-day average of 57.59K — lighter than usual.
- Price is -31.1% vs its 50-day average ($6.25) and -44.5% vs its 200-day average ($7.75).
- 52-week range $4.30–$42.20; today's close sits at 0% of that range, 89.8% below the 52-week high.
- That makes 7 straight losses.
Oct 8, 2026 — ONMD dips 1.8% to $4.82, a 52-week low, 6 down days in a row
- Closed at $4.82, -1.83% vs the prior close of $4.91. Day range $4.72–$4.91, opened at $4.89.
- Volume was 28.30K shares, 0.3x its 50-day average of 98.45K — lighter than usual.
- Price is -23.6% vs its 50-day average ($6.30) and -38.2% vs its 200-day average ($7.80).
- 52-week range $4.72–$42.20; today's close sits at 0% of that range, 88.6% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — ONMD dips 1.2% to $4.91, a 52-week low, 5 down days in a row
- Closed at $4.91, -1.21% vs the prior close of $4.97. Day range $4.90–$5.14, opened at $4.92.
- Volume was 30.10K shares, 0.2x its 50-day average of 143.71K — lighter than usual.
- Price is -22.5% vs its 50-day average ($6.34) and -37.4% vs its 200-day average ($7.84).
- 52-week range $4.90–$42.20; today's close sits at 0% of that range, 88.4% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — ONMD dips 2.7% to $4.97, a 52-week low, 4 down days in a row
- Closed at $4.97, -2.74% vs the prior close of $5.11. Day range $4.97–$5.26, opened at $5.09.
- Volume was 48.50K shares, 0.3x its 50-day average of 142.94K — lighter than usual.
- Price is -22.1% vs its 50-day average ($6.38) and -36.9% vs its 200-day average ($7.88).
- 52-week range $4.90–$42.20; today's close sits at 0% of that range, 88.2% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — ONMD slides 5.2% to $5.11, a 3-month low, 3 down days in a row
- Closed at $5.11, -5.19% vs the prior close of $5.39. Day range $5.11–$5.52, opened at $5.36.
- Volume was 33.30K shares, 0.2x its 50-day average of 142.39K — lighter than usual.
- Price is -20.2% vs its 50-day average ($6.40) and -35.5% vs its 200-day average ($7.92).
- 52-week range $4.90–$42.20; today's close sits at 1% of that range, 87.9% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ONMD dips 2.0% to $5.39
- Closed at $5.39, -2.00% vs the prior close of $5.50. Day range $5.35–$5.64, opened at $5.55.
- Volume was 38.20K shares, 0.3x its 50-day average of 141.79K — lighter than usual.
- Price is -16.1% vs its 50-day average ($6.42) and -32.3% vs its 200-day average ($7.96).
- 52-week range $4.90–$42.20; today's close sits at 1% of that range, 87.2% below the 52-week high.
ONMD latest news & SEC filings
Every SEC filing by or about ONMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kosasa Thomas bought 129,758 shares at $5.78 (≈$750.00K) on Oct 7, 2026; now holds 1,983,573
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Yu Jeffrey bought 45,126 shares at $5.54 (≈$250.00K) on Oct 9, 2026; now holds 896,840
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Golden Robert Lawrence received an award of 10,000 shares on Jan 1, 2026; now holds 64,791
- Golden Robert Lawrence received an award of 35,000 shares on Jul 6, 2026; now holds 99,791
- Golden Robert Lawrence sold 2,500 shares at $6.60 (≈$16.50K) on Sep 14, 2026; now holds 97,291
- Golden Robert Lawrence sold 3,000 shares at $6.30 (≈$18.90K) on Sep 15, 2026; now holds 94,291
- Golden Robert Lawrence sold 3,000 shares at $6.63 (≈$19.89K) on Sep 21, 2026; now holds 91,291
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Green Aaron received an award of 65,000 shares on Jul 6, 2026; now holds 254,638
- Green Aaron sold 5,000 shares at $7.39 (≈$36.96K) on Sep 22, 2026; now holds 249,638
- Green Aaron sold 1,667 shares at $6.48 (≈$10.80K) on Sep 24, 2026; now holds 247,971
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 30, 2026 · 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 23, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Sep 14, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Yu Jeffrey bought 142,857 shares at $0.63 (≈$90.00K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 · 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 19, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 14, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $292.00K (prior year $155.00K) (+88.4% vs Jun 30, 2025)
- Net income: -$2.17M (prior year $2.98M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.04 (prior year $0.07) (loss widened vs Jun 30, 2025)
Aug 7, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kosasa Thomas bought 1,449,275 shares at $0.69 (≈$1,000.00K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade ONMD
- Last results release: May 23, 2024 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 6.35% (largest 17.7%). That is a volatile stock.
- Liquidity: about 77.17K shares (≈$366.54K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.75 vs a range of $3.61–$31.00 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Sep 29, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 23 open-market buys, 2 sales; latest: Jeffrey Yu bought 142,857 shares on Sep 10, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 29, 2026; 8-K Sep 23, 2026.
- Share count: 59.29M shares outstanding (Aug 11, 2026), +28.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
ONMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.63 | 4.79 | 4.40 | 4.75 | 28.30K |
| Oct 14, 2026 | 4.41 | 4.71 | 4.12 | 4.71 | 104.60K |
| Oct 13, 2026 | 3.88 | 4.07 | 3.61 | 4.02 | 37.10K |
| Oct 12, 2026 | 4.18 | 4.22 | 3.90 | 3.93 | 42.80K |
| Oct 9, 2026 | 4.79 | 4.84 | 4.30 | 4.30 | 24.70K |
| Oct 8, 2026 | 4.89 | 4.91 | 4.72 | 4.82 | 28.30K |
| Oct 7, 2026 | 4.92 | 5.14 | 4.90 | 4.91 | 30.10K |
| Oct 6, 2026 | 5.09 | 5.26 | 4.97 | 4.97 | 48.50K |
| Oct 5, 2026 | 5.36 | 5.52 | 5.11 | 5.11 | 33.30K |
| Oct 2, 2026 | 5.55 | 5.64 | 5.35 | 5.39 | 38.20K |
| Oct 1, 2026 | 5.71 | 5.79 | 5.46 | 5.50 | 67.00K |
| Sep 30, 2026 | 5.60 | 5.88 | 5.32 | 5.78 | 410.30K |
| Sep 29, 2026 | 6.33 | 6.33 | 5.20 | 5.21 | 85.80K |
| Sep 28, 2026 | 6.30 | 6.50 | 6.27 | 6.33 | 56.67K |
| Sep 25, 2026 | 6.92 | 7.30 | 6.00 | 6.50 | 144.39K |
| Sep 24, 2026 | 6.54 | 7.15 | 6.35 | 7.05 | 21.64K |
| Sep 23, 2026 | 6.50 | 6.70 | 6.33 | 6.55 | 24.82K |
| Sep 22, 2026 | 7.07 | 7.80 | 6.50 | 6.50 | 109.16K |
| Sep 21, 2026 | 6.68 | 7.20 | 6.60 | 6.88 | 33.77K |
| Sep 18, 2026 | 7.08 | 7.30 | 6.40 | 7.00 | 173.86K |
About OneMedNet
OneMedNet (ONMD) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in SURREY, United Kingdom. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1849380.
ONMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kenneth Alleyne | Director | Nov 26, 2025 |
| Eric Casaburi | Director | Nov 26, 2025 |
| Jair Clarke | Director | Nov 26, 2025 |
| Robert Lawrence Golden | Chief Financial Officer | Nov 26, 2025 |
| Aaron Green | Chief Executive Officer | Jun 24, 2026 |
| Thomas Kosasa | Director | Aug 7, 2026 |
| Sherry Coonse Mccraw | Director | Nov 26, 2025 |
| Jeffrey Yu | Chief Medical Officer | Sep 14, 2026 |
| Andrew B Zeinfeld | Director | Nov 26, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert Lawrence Golden | Chief Financial Officer | Nov 26, 2025 |
| Aaron Green | Chief Executive Officer | Jun 24, 2026 |
| Jeffrey Yu | Chief Medical Officer | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Jeffrey Yu | Buy | 142,857 | $0.63 |
| Jul 30, 2026 | Thomas Kosasa | Buy | 1,449,275 | $0.69 |
| Jun 23, 2026 | Jeffrey Yu | Buy | 158,730 | $0.63 |
| Jun 23, 2026 | Aaron Green | Buy | 36,650 | $0.57 |
| Jun 16, 2026 | Jeffrey Yu | Buy | 172,414 | $0.58 |
| Jun 15, 2026 | Aaron Green | Buy | 18,702 | $0.54 |
| Jun 12, 2026 | Aaron Green | Buy | 36,920 | $0.56 |
| Jun 12, 2026 | Thomas Kosasa | Buy | 158,730 | $0.63 |
| May 18, 2026 | Thomas Kosasa | Buy | 268,817 | $0.93 |
| Apr 23, 2026 | Thomas Kosasa | Buy | 280,898 | $0.89 |
| Apr 1, 2026 | Jeffrey Yu | Buy | 903,614 | $0.83 |
| Feb 6, 2026 | Thomas Kosasa | Buy | 595,238 | $0.84 |
| Nov 18, 2025 | Aaron Green | Sale | 61,555 | $1.20 |
| Oct 22, 2025 | Aaron Green | Sale | 64,767 | $2.23 |
| Oct 15, 2025 | Eric Casaburi | Buy | 10,000 | $3.05 |
ONMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.36M | $-2.80M | -0.06 | $-7.50M |
| Dec 31, 2024 | $643.00K | $-10.13M | -0.36 | $-6.95M |
| Dec 31, 2023 | $1.02M | $-33.78M | -4.65 | $-4.79M |
| Dec 31, 2022 | $1.15M | $-6.23M | 0.03 | $87.24M |
| Dec 31, 2021 | — | $5.14M | 0.44 | $-378.49K |
Latest balance sheet: total assets $1.36M, total liabilities $4.88M, cash $358.00K (as of Jun 30, 2026).
ONMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 23, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Medpace (MEDP)Incyte (INCY)Icon (ICLR)Absci (ABSI)Maxcyte (MXCT)OmniAb (OABI)Nrc Health (NRC)bioAffinity Technologies (BIAF)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ONMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.